History of S. aureus Skin Infection Significantly Associates with History of Eczema Herpeticum in Patients with Atopic Dermatitis
- PMID: 37615834
- PMCID: PMC10539263
- DOI: 10.1007/s13555-023-00996-y
History of S. aureus Skin Infection Significantly Associates with History of Eczema Herpeticum in Patients with Atopic Dermatitis
Abstract
Introduction: Patients with atopic dermatitis (AD) are uniquely susceptible to a number of serious viral skin complications, including eczema herpeticum (EH), caused by herpes simplex virus. This study explored the associations between biomarkers of epithelial barrier dysfunction, type 2 immunity, Staphylococcus aureus infection, and S. aureus-specific immunoglobulin responses in a cohort of AD subjects with and without a history of EH (EH+ and EH-, respectively).
Methods: A total of 112 subjects with AD (56 EH+, 56 EH-), matched by age and AD severity, were selected from a registry of over 3000 AD subjects. Logistic regression was used to test the association between history of S. aureus skin infection and history of EH, while controlling for a number of confounders.
Results: Compared to those without a history of S. aureus skin infection, subjects with a history of S. aureus skin infection were found to have more than sixfold increased odds of having a history of EH (6.60, 95% confidence interval [CI]: 2.00-21.83), after adjusting for history of other viral skin infections (molluscum contagiosum virus, human papillomavirus), serum total IgE, and IgG against the S. aureus virulence factor SElX.
Conclusions: These findings indicate an important relationship between S. aureus skin infections and EH.
Keywords: Atopic dermatitis; Eczema herpeticum; Immunoglobulins; S. aureus; Viral skin infections.
© 2023. The Author(s).
Conflict of interest statement
ADB: Consultant for Abbvie, Incyte Corporation, Sanofi-Advent, dMed Biopharmaceutical Co, Ltd; grant or clinical trial support (grants paid to the institution) from Incyte Crp, Dermira, Kiniksa, Novartis, and Pfizer. LCS: Consultant for Sanofi Genzyme, Abbvie, Leo Pharma; Investigator for Regeneron, DBV Technologies, DSMB-Alladapt Immunotherapeutics, DAIT/NIAID. PYO: Consultant for Incyte, Abbvie, Janssen; Investigator for Regeneron, Sanofi Genzyme, Leo, Incyte. ELS: Personal fees from Advances in Cosmetic Medical Derm Hawaii LLC, AbbVie, Amgen, AOBiome LLC, Arcutis Biotherapeutics, Arena Pharmaceuticals, Aslan Pharma, Boehringer Ingelheim USA, Inc., Boston Consulting Group, Bristol Myers Squibb–BMS, Collective Acumen LLC (CA), CorEvitas, Dermira, Eli Lilly, Evelo Biosciences, Evidera, ExcerptaMedica, FIDE, Forte Bio RX, Galderma, GlaxoSmithKline, Incyte, Janssen, Johnson & Johnson, Kyowa Kirin Pharmaceutical Development, Leo Pharm, Medscape LLC, Merck, MauiDerm, MLG Operating, MJH holding, Pfizer, Physicians World LLC, PRImE, Regeneron, Revolutionizing Atopic Dermatitis Inc, Roivant, Sanofi-Genzyme, Trevi therapeutics, Valeant, Vindico Medical education, WebMD. DYML: Consultant for Aslan Pharma, Genentech, LEO Pharma, and Incyte; Research grants from Sanofi Genzyme. BLM: Named inventor on patents and patent applications related to the Arrayed Imaging Reflectometry (AIR) technology. LAB: Consultant for Allakos, Arena Pharmaceuticals, DermTech, Evelo Biosciences, Galderma, Incyte, Janssen, LEO Pharma, Merck, Numab Therapeutics, Pfizer, Rapt Therapeutics, Regeneron, Ribon Therapeutics, Sanofi/Genzyme, Sanofi-Aventis, Stealth BioTherapeutics, Trevi Therapeutics, Union Therapeutics, and Xencor. DMC member: Novartis; Investigator for Abbvie, Astra-Zeneca, DermTech, Kiniksa, Pfizer, Regeneron, Ribon Therapeutics and Sanofi. MCM, AK, TY and CLS have no conflicting interests to disclose.
Figures


Similar articles
-
Relationship Between the Presence of Eczema Herpeticum and the Significance of Clinical and Laboratory Tests in Korean Children With Atopic Dermatitis.Iran J Pediatr. 2016 Jun 18;26(4):e4683. doi: 10.5812/ijp.4683. eCollection 2016 Aug. Iran J Pediatr. 2016. PMID: 27713812 Free PMC article.
-
Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonization.J Allergy Clin Immunol. 2011 Jan;127(1):186-93, 193.e1-11. doi: 10.1016/j.jaci.2010.10.033. J Allergy Clin Immunol. 2011. PMID: 21211653 Free PMC article.
-
Staphylococcal TSST-1 Association with Eczema Herpeticum in Humans.mSphere. 2021 Aug 25;6(4):e0060821. doi: 10.1128/mSphere.00608-21. Epub 2021 Jul 28. mSphere. 2021. PMID: 34319127 Free PMC article.
-
Eczema herpeticum in atopic dermatitis.Allergy. 2021 Oct;76(10):3017-3027. doi: 10.1111/all.14853. Epub 2021 May 3. Allergy. 2021. PMID: 33844308 Review.
-
The Genetics of Eczema Herpeticum.Clin Rev Allergy Immunol. 2022 Dec;63(3):390-397. doi: 10.1007/s12016-022-08953-x. Epub 2022 Sep 17. Clin Rev Allergy Immunol. 2022. PMID: 36114947 Review.
Cited by
-
Lambda Theta Reflectometry: A New Technique for Measuring Optical Film Thickness in Planar Protein Arrays.ACS Sens. 2025 Jul 25;10(7):5097-5107. doi: 10.1021/acssensors.5c01108. Epub 2025 Jul 2. ACS Sens. 2025. PMID: 40600954 Free PMC article.
-
Lambda Theta Reflectometry: a new technique to measure optical film thickness applied to planar protein arrays.bioRxiv [Preprint]. 2025 Mar 29:2025.03.26.645463. doi: 10.1101/2025.03.26.645463. bioRxiv. 2025. Update in: ACS Sens. 2025 Jul 25;10(7):5097-5107. doi: 10.1021/acssensors.5c01108. PMID: 40196501 Free PMC article. Updated. Preprint.
References
Grants and funding
LinkOut - more resources
Full Text Sources